T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Autodesk
ADSK
$52.7B
| $175M | 0.02% |
591,107
-229,151
| -28% | -$69.3M |
|
502
Dutch Bros
BROS
$8.91B
| $173M | 0.02% |
2,824,546
-625,891
| -18% | -$35.6M |
|
503
Molina Healthcare
MOH
$10.8B
| $173M | 0.02% |
994,260
-2,509,415
| -72% | -$412M |
|
504
United Therapeutics
UTHR
$21.9B
| $172M | 0.02% |
352,086
+51,155
| +17% | +$23.8M |
|
505
VF Corp
VFC
$5.73B
| $171M | 0.02% |
9,432,379
-3,065,145
| -25% | -$49.7M |
|
|
DOO
506
Bombardier Recreational Products
DOO
$4.69B
| $169M | 0.02% |
2,393,165
-14,642
| -0.6% | -$997K |
|
507
AXIS Capital
AXS
$7.26B
| $169M | 0.02% |
1,581,179
-282,833
| -15% | -$28.1M |
|
508
Carpenter Technology
CRS
$26.3B
| $169M | 0.02% |
536,887
-52,230
| -9% | -$15.7M |
|
509
Kinder Morgan
KMI
$70.7B
| $168M | 0.02% |
6,125,554
-2,134,446
| -26% | -$57.7M |
|
510
JFrog
FROG
$10.4B
| $168M | 0.02% |
2,683,153
+633,231
| +31% | +$36M |
|
511
Marvell Technology
MRVL
$195B
| $168M | 0.02% |
1,971,772
-1,478,439
| -43% | -$129M |
|
512
e.l.f. Beauty
ELF
$5.47B
| $167M | 0.02% |
2,197,319
+711,540
| +48% | +$70M |
|
513
Rhythm Pharmaceuticals
RYTM
$8.1B
| $167M | 0.02% |
1,560,847
+160,950
| +11% | +$17.1M |
|
|
BA.PRA
514
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.19B
| – | – |
0
| – | – |
|
515
Comfort Systems
FIX
$61.2B
| $166M | 0.02% |
177,616
-23,216
| -12% | -$21.4M |
|
516
Main Street Capital
MAIN
$5.47B
| $165M | 0.02% |
2,734,461
+162,580
| +6% | +$9.59M |
|
517
iQIYI
IQ
$1.28B
| $165M | 0.02% |
85,883,309
+41,011,384
| +91% | +$87.8M |
|
518
Procore
PCOR
$8.81B
| $165M | 0.02% |
2,262,157
+210,692
| +10% | +$15.6M |
|
519
OneMain Financial
OMF
$7.44B
| $164M | 0.02% |
2,431,480
-201,198
| -8% | -$12.2M |
|
520
Summit Therapeutics
SMMT
$12B
| $164M | 0.02% |
9,371,415
+4,832,592
| +106% | +$90.9M |
|
521
Airbnb
ABNB
$108B
| $164M | 0.02% |
1,205,993
+398,089
| +49% | +$49.6M |
|
522
Westlake Corp
WLK
$10.1B
| $163M | 0.02% |
2,208,715
+572
| +0% | +$40.7K |
|
523
Zoetis
ZTS
$30.4B
| $163M | 0.02% |
1,291,915
+252,725
| +24% | +$33M |
|
524
Veralto
VLTO
$23.6B
| $161M | 0.02% |
1,612,780
+227,244
| +16% | +$23M |
|
525
EPAM Systems
EPAM
$5.17B
| $161M | 0.02% |
784,101
+701,500
| +849% | +$125M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.